Senomyx, Inc. discovers, develops, and commercializes flavor ingredients and natural high intensity sweeteners primarily for the packaged food, beverage, and ingredient supply industries in the United States. The company develops and/or commercializes sweet, savory and salt flavor ingredients, bitter blockers and cooling agents. It sells various flavor ingredients directly to flavor companies. The company has collaboration agreements with Ajinomoto Co., Inc.; Firmenich SA; and PepsiCo, Inc. Senomyx, Inc. was founded in 1998 and is headquartered in San Diego, California.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Commercial physical research
Sub-IndustryN/A
SectorConsumer Staples
SymbolNASDAQ:SNMX
CUSIPN/A
Phone858-646-8300
Debt
Debt-to-Equity RatioN/A
Current Ratio5.43
Quick Ratio5.02
Price-To-Earnings
Trailing P/E Ratio-40.00
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$29.32 million
Price / Sales1.98
Cash FlowN/A
Price / CashN/A
Book Value$0.39 per share
Price / Book3.08
Profitability
EPS (Most Recent Fiscal Year)($0.03)
Net Income$-1,260,000.00
Net Margins-5.66%
Return on Equity-10.75%
Return on Assets-7.06%
Miscellaneous
Employees56
Outstanding Shares48,300,000
Market Cap$57.96
Senomyx (NASDAQ:SNMX) Frequently Asked Questions
What is Senomyx's stock symbol?
Senomyx trades on the NASDAQ under the ticker symbol "SNMX."
How were Senomyx's earnings last quarter?
Senomyx Inc. (NASDAQ:SNMX) posted its earnings results on Thursday, April, 26th. The specialty chemicals company reported ($0.08) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.07) by $0.01. The specialty chemicals company had revenue of $3.11 million for the quarter. Senomyx had a negative return on equity of 10.75% and a negative net margin of 5.66%. View Senomyx's Earnings History.
What is the consensus analysts' recommendation for Senomyx?
0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Senomyx in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."
Who are some of Senomyx's key competitors?
Some companies that are related to Senomyx include Anavex Life Sciences (AVXL), HedgePath Pharmaceuticals (HPPI), Luna Innovations (LUNA), Dyadic International, Inc common stock (DYAI), Vitality Biopharma (VBIO), BIOQUAL (BIOQ), Cleveland BioLabs (CBLI), Protalex (PRTX), Bioanalytical Systems (BASI), US Stem Cell (USRM), Tenax Therapeutics (TENX), Geovax Labs (GOVX), ALGAE TEC Ltd/S (ALGXY) and Redpoint Bio (RPBC).
Who are Senomyx's key executives?
Senomyx's management team includes the folowing people:
- Mr. Kent Snyder, Exec. Chairman (Age 64)
- Mr. John W. Poyhonen MBA, Chief Exec. Officer, Pres and Director (Age 58)
- Ms. Catherine C. Lee, Sr. VP, Gen. Counsel & Corp. Sec. (Age 44)
- Ms. Sharon Wicker, Sr. VP & Chief Commercial Devel. Officer (Age 62)
- Mr. David C. Humphrey, VP of Fin.
Has Senomyx been receiving favorable news coverage?
News headlines about SNMX stock have been trending somewhat positive recently, according to Accern Sentiment. Accern rates the sentiment of press coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Senomyx earned a news impact score of 0.17 on Accern's scale. They also assigned media stories about the specialty chemicals company an impact score of 45.04 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
How do I buy shares of Senomyx?
Shares of SNMX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Senomyx's stock price today?
One share of SNMX stock can currently be purchased for approximately $1.20.
How big of a company is Senomyx?
Senomyx has a market capitalization of $57.96 million and generates $29.32 million in revenue each year. The specialty chemicals company earns $-1,260,000.00 in net income (profit) each year or ($0.03) on an earnings per share basis. Senomyx employs 56 workers across the globe.
How can I contact Senomyx?
Senomyx's mailing address is 4767 NEXUS CENTRE DRIVE, SAN DIEGO CA, 92121. The specialty chemicals company can be reached via phone at 858-646-8300 or via email at [email protected]
MarketBeat Community Rating for Senomyx (NASDAQ SNMX)
MarketBeat's community ratings are surveys of what our community members think about Senomyx and other stocks. Vote "Outperform" if you believe SNMX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNMX will underperform the S&P 500 over the long term. You may vote once every thirty days.
